21 Jan 2022 , 01:43 PM
Net profit of Supriya Lifescience rose 152.65% to Rs 39.64 crore in the quarter ended December 2021 as against Rs 15.69 crore during the previous quarter ended December 2020. Sales rose 45.00% to Rs 117.00 crore in the quarter ended December 2021 as against Rs 80.69 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 117.00 | 80.69 | 45 |
| OPM % | 32.80 | 32.00 | – |
| PBDT | 42.67 | 29.34 | 45 |
| PBT | 40.07 | 24.55 | 63 |
| NP | 39.64 | 15.69 | 153 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
